CX 2023 Preliminary programme

Showing the latest CX 2023 Preliminary Programme, talks, speakers and timings subject to change. Stay tuned for even more talk announcements and exciting session additions.

All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter the timings if necessary.

Day 1 Morning: Peripheral Arterial & Acute Limb Ischaemia & Randomised Control Trial Update - Tuesday, 25th April
Venue:   Kensington 1 / Livestream 1
Peripheral Arterial Consensus Update
Challenging the status quo of SFA treatment
Speaker:   Maarit Venermo, Helsinki, Finland
Audience Participation & Discussion
SFA Intervention - What DES data suggest are best
Speaker:   Peter Schneider, San Francisco, United States
Audience Participation & Discussion
Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis
Speaker:   Marianne Brodmann, Graz, Austria
Audience Participation & Discussion
Edited Case: Optimising PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study
Speaker:   Michael Lichtenberg, Arnsberg, Germany
Audience Participation & Discussion
Directional atherectomy followed by drug-coated balloons to treat long, calcified femoropopliteal artery lesions: The REALITY study
Speaker:   Thomas Zeller, Bad Krozingen, Germany
Audience Participation & Discussion
Increasing supervised exercise therapy capacity for claudicates without additional vascular resource - The advantage of integrating public health services into vascular clinical pathways
Speaker:   Naseer Ahmad, Manchester, United Kingdom
Audience Participation & Discussion
Edited Case: MIMICS-3D 3-year results: Compelling clinical outcomes in complex patients and lesions
Speaker:   Michael Lichtenberg, Arnsberg, Germany
Audience Participation & Discussion
Five-year outcomes of drug-coated balloon treatment for femoropopliteal artery disease: DCB safety and effectiveness across real-world subgroups / reintervention patterns among patients with in-stent restenosis, long lesions, and chronic total occlusions
Speaker:   Gunnar Tepe, Rosenheim, Germany
Audience Participation & Discussion
A patient-level pooled analysis of drug-coated balloons versus bare metal stents for the treatment of symptomatic femoropopliteal disease
Speaker:   Thomas Zeller, Bad Krozingen, Germany
Audience Participation & Discussion
Edited Case: Is transradial the new approach for peripheral artery treatment
Speaker:   Marianne Brodmann, Graz, Austria
Audience Participation & Discussion
 
Sponsored Education
Coffee Break
Acute Limb Ischaemia Consensus Update
Primary endpoint results of the STRIDE trial on thrombectomy for acute limb ischemia
Speaker:   Sean Lyden, Cleveland, United States
Audience Participation & Discussion
 
Sponsored Education - Penumbra
Randomised Control Trial Consensus Update
Podium First: BASIL 2
Speaker:   Andrew Bradbury, Birmingham, United Kingdom
Audience Participation & Discussion
Podium First: BEST CLI clinical trial update
Speaker:   Matthew Menard, Boston, United States
Audience Participation & Discussion
Podium First: BEST CLI quality of life data
Speaker:   Alik Farber, Boston, United States
Audience Participation & Discussion
Roundtable Discussion
 
Lunch Break